RESUMEN
BACKGROUND: Discrepancies in the results from studies of early events in human trophoblast invasion of decidua have been acknowledged and are attributed largely to deficiencies in the accuracy of sampling of the decidual tissue used in the research. We describe a novel technique of biopsy of decidua parietalis and basalis that overcomes the issue of accuracy of site of the biopsy. METHODS & RESULTS: The technique is applicable to pregnancies undergoing first trimester surgical termination. Following cervical dilatation, a rigid hysteroscope is introduced into the cervical canal. The pressure of the saline distending medium shears the membranes of the gestation sac away from the decidua parietalis, leaving the pregnancy suspended at the site of the early placenta (the decidual basalis). Under direct vision a biopsy forceps is used to sample the decidua parietalis, and then the forceps is introduced beneath the gestation sac to sample the decidua basalis. Morphological and immunohistochemical studies have confirmed the accuracyof site and adequacy of the samples, with a 40% myometrial spiral artery success rate. CONCLUSION: This is a simple novel technique of decidual biopsy under direct vision which allows for high accuracy of the site of biopsy material, and therefore has the potential to revolutionize research on trophoblast-decidua interactions during the critical early stages of human pregnancy.
Asunto(s)
Biopsia/métodos , Decidua/patología , Histeroscopía/métodos , Adulto , Decidua/fisiología , Femenino , Humanos , Embarazo , Primer Trimestre del Embarazo , Trofoblastos/fisiología , Ultrasonografía PrenatalAsunto(s)
Transfusión de Eritrocitos/métodos , Enfermedades Gastrointestinales/tratamiento farmacológico , Hepatopatías/tratamiento farmacológico , Enfermedades Mitocondriales/tratamiento farmacológico , Enfermedades del Sistema Nervioso Periférico/tratamiento farmacológico , Timidina Fosforilasa/uso terapéutico , Adulto , Desoxiuridina/orina , Sistemas de Liberación de Medicamentos , Eritrocitos/enzimología , Resultado Fatal , Femenino , Enfermedades Gastrointestinales/enzimología , Enfermedades Gastrointestinales/fisiopatología , Predisposición Genética a la Enfermedad/genética , Humanos , Hepatopatías/enzimología , Hepatopatías/fisiopatología , Enfermedades Mitocondriales/enzimología , Enfermedades Mitocondriales/fisiopatología , Mutación/genética , Enfermedades del Sistema Nervioso Periférico/enzimología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Neumonía/complicaciones , Síndrome , Timidina/orina , Timidina Fosforilasa/genética , Insuficiencia del TratamientoRESUMEN
Polyethylene glycol-conjugated adenosine deaminase (pegademase) is used for enzyme replacement therapy for patients with severe combined immunodeficiency caused by adenosine deaminase deficiency. The entrapment of pegademase within human energy-replete carrier erythrocytes using a hypo-osmotic dialysis procedure was investigated with the objective of prolonging the in vivo circulatory half-life of the enzyme and maintaining therapeutic blood levels. Native unmodified adenosine deaminase (ADA) was similarly studied. The efficiency of pegademase entrapment was low (9%) whereas the entrapment of native unmodified ADA was substantial (50%), suggesting that the polyethylene glycol side-chains were impeding intracellular entrapment. The biochemical characteristics and the osmotic fragility of these carrier erythrocytes were not adversely affected by the entrapment of either pegademase or native ADA. In vivo survival studies of pegademase-loaded 51Cr-labelled carrier erythrocytes in an ADA-deficient adult patient showed a mean cell half-life of 16 d. Carrier erythrocyte-entrapped pegademase and native ADA had in vivo half-lives of 20 and 12.5 d, respectively, demonstrating that entrapment prolongs the half-life over that of plasma pegademase, which has a circulating half-life of 3-6 d. These results provide the basis for a more extensive clinical evaluation of carrier erythrocyte-entrapped native adenosine deaminase therapy.
Asunto(s)
Adenosina Desaminasa/administración & dosificación , Adenosina Desaminasa/deficiencia , Eritrocitos , Inmunodeficiencia Combinada Grave/tratamiento farmacológico , Adenosina Desaminasa/sangre , Adulto , Portadores de Fármacos , Femenino , Semivida , Humanos , Inmunodeficiencia Combinada Grave/enzimologíaRESUMEN
The effects of human recombinant bone morphogenetic protein-2 (rhBMP-2) on rabbit fractures healing under both stable and unstable mechanical conditions were investigated. rhBMP-2 was administered (1) on bioerodible particles, (2) in a collagen gel, and (3) by injection. rhBMP-2 on bioerodible particles has no effect as the particles prevent the migration of cells that produce the callus. The collagen gel is resorbed more rapidly; the development of the callus of mechanically unstable fractures is similar to controls at 14 days. When rhBMP-2 is injected, the callus of mechanically unstable fractures develops more rapidly so that cortical union occurs by 21 days, as compared with 28 days in control fractures. The effects on fractures healing under stable mechanical conditions are minimal. It is argued that mechanical factors influence the size of the callus of normally healing fractures and, although BMP-2 accelerates the rate of development of the callus and cortical union, it does not affect the amounts of bone and cartilage produced.
Asunto(s)
Proteínas Morfogenéticas Óseas/farmacología , Callo Óseo/efectos de los fármacos , Curación de Fractura/efectos de los fármacos , Fracturas de la Tibia/tratamiento farmacológico , Factor de Crecimiento Transformador beta , Animales , Materiales Biocompatibles , Biodegradación Ambiental , Proteína Morfogenética Ósea 2 , Proteínas Morfogenéticas Óseas/administración & dosificación , Callo Óseo/patología , Callo Óseo/fisiología , Cartílago/efectos de los fármacos , Cartílago/patología , Cartílago/fisiología , Colágeno , Vías de Administración de Medicamentos , Portadores de Fármacos , Curación de Fractura/fisiología , Humanos , Masculino , Conejos , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/farmacología , Soporte de Peso/fisiologíaRESUMEN
Erythrocytes offer the exciting opportunity of being used as carriers of therapeutic agents. Encapsulation within erythrocytes will give the therapeutic agent a clearance equivalent to the normal life of the erythrocyte therefore maintaining therapeutic blood levels over prolonged periods and also giving a sustained delivery to the monocyte-macrophage system (reticulo-endothelial system). Both the dose and frequency of therapeutic interventions could thus be reduced. Ensuring a near-physiological survival time of carrier erythrocytes is essential to their successful use as a sustained drug delivery system, and this has not been demonstrated in man. In this study we assessed the survival in vivo of autologous unloaded energy-replete carrier erythrocytes in nine volunteers, using a standard 51Cr erythrocyte-labelling technique. Within 144 h after infusion there was a 3 to 49% fall in circulating labelled cells, followed thereafter by an almost complete return to initial circulating levels; surface counting demonstrated an initial sequestration of erythrocytes by the spleen and subsequent release. Mean cell life and cell half-life of the carrier erythrocytes were within the normal range of 89 to 131 days and 19 to 29 days respectively. These results demonstrate the viability of carrier erythrocytes as a sustained drug delivery system.
Asunto(s)
Portadores de Fármacos , Envejecimiento Eritrocítico , Adulto , Radioisótopos de Cromo , Diálisis , Recuento de Eritrocitos , Femenino , Corazón , Humanos , Pulmón , Masculino , Bazo , Factores de TiempoRESUMEN
Energy metabolism and glycolysis of normal human term placental trophoblast in two-sided culture was investigated during differentiation from cytotrophoblast to syncytiotrophoblast, because glycogen metabolism is abnormal in several trophoblast related pregnancy diseases, including pre-eclampsia. After initial recovery of energy and cytoplasmic NADH/NAD+ redox by 24 h of culture, measures of cellular energy state, [ATP], [ADP], [ATP]/[ADP] ratio, ([ATP] + [ADP] + [AMP]), [ATP]/([ATP] + [ADP] + [AMP]) and energy charge remained essentially constant until 72 h, despite periods of increased energy turnover. At 24 h there was a burst of glycogenolysis, and glycolysis indicated by increased lactate production, which coincided with formation of syncytium. Subsequently, there was no resynthesis nor further breakdown of glycogen. At 48 h, oxygen consumption temporarily increased substantially, without increased glycolysis, during functional differentiation of the syncytiotrophoblast. Glucose uptake was constant and largely from the basal (in vivo fetal facing) side. Lactate output into the basal fetal medium was twice as fast as that into the microvillous (maternal) medium, and oxygen uptake was also asymmetrical. The results show that before and after differentiation substantial relatively constant aerobic glycolysis occurs, but that during increased energy demand cytotrophoblast depends on both glycolytic and aerobic energy production whereas syncytiotrophoblast relies on aerobic metabolism.
Asunto(s)
Diferenciación Celular , Metabolismo Energético , Glucólisis , Placenta/citología , Trofoblastos/citología , Trofoblastos/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Monofosfato/metabolismo , Adenosina Trifosfato/metabolismo , Células Cultivadas , Femenino , Glucógeno/metabolismo , Humanos , Cinética , Lactatos/metabolismo , Microscopía Electrónica , Embarazo , Piruvatos/metabolismo , Factores de Tiempo , Trofoblastos/ultraestructuraRESUMEN
Criteria for a successful model for the study of trans-syncytiotrophoblast transfer include isolating substantially pure trophoblast cells from placental villous tissue, and obtaining from them phenotypical villous syncytial syncytiotrophoblast during culture. For studies involving the basal membrane, including overall transfer, basal uptake and output, and controls acting at the basal membrane, a two-sided model is required with a separate compartment of culture medium in contact with the basal cell surface. All current methods of isolating cytotrophoblast, the precursor of syncytiotrophoblast, derive from the original tissue trypsinization method of Thiede (1960), which produces cultures of villous cytotrophoblast cells contaminated with other placental cell types. Lessons learned from successful and unsuccessful development of the model over 35 years are outlined, and recently established methods for purifying the isolated mixed cells discussed. These include sedimentation and centrifugation methods, immunological and receptor binding methods, and more selective release of trophoblast cells from tissue. Immuno flow cytometric cell sorting methods are potentially capable of isolating subpopulations of various phenotypical trophoblast types. We conclude that satisfactory methods are now available for isolating and purifying cytotrophoblast from early or late gestation human placenta.
Asunto(s)
Intercambio Materno-Fetal , Trofoblastos/citología , Separación Celular/métodos , Femenino , Humanos , EmbarazoRESUMEN
The conditions necessary for producing syncytical syncytiotrophoblast are examined. Tissue disaggregation conditions, culture media composition, different extracellular matrices and the influence of placental gestational age are all assessed. The importance of evaluating the biochemical and functional differentiational state of the cells is also stressed. Evidence is summarized that syncytiotrophoblast in culture is morphologically and ultrastructurally very similar to syncytiotrophoblast in vivo, and what is so far known biochemically is largely consistent with what is known in vivo. Studies published to date on microvillous membrane uptake and release and relationships with intracellular metabolism using syncytiotrophoblast in conventional culture are outlined from the point of view of the advantages and potential of this model. The present state of development of the two-sided model is assessed, mentioning factors to be considered such as the supporting membrane to be used, accounting for passive diffusion and paracellular leak components of transport and dealing with quantitative effects in kinetic studies of the presence of the supporting membrane. It is concluded that satisfactory methods are now in place for preparing pure villous syncytial syncytiotrophoblast in culture from cytotrophoblast derived from term (but not early) placentae, suitable for studying microvillous membrane transport and relationships with intracellular metabolism. Cytotrophoblast from early gestational age placenta may require different conditions to form true syncytiotrophoblast. A two-sided model for studies of overall transfer, basal transport and basal control mechanisms is now available and possibly with some development should be a good model for such investigations.
Asunto(s)
Intercambio Materno-Fetal , Trofoblastos/citología , Técnicas de Cultivo de Célula , Separación Celular , Femenino , Edad Gestacional , Humanos , EmbarazoAsunto(s)
Eritrocitos/enzimología , Glucosilceramidasa/administración & dosificación , Diálisis , Portadores de Fármacos , Metabolismo Energético , Enfermedad de Gaucher/tratamiento farmacológico , Enfermedad de Gaucher/enzimología , Glucosilceramidasa/sangre , Glucosilceramidasa/deficiencia , Humanos , Técnicas In VitroAsunto(s)
Adenosina Desaminasa/administración & dosificación , Inmunodeficiencia Combinada Grave/tratamiento farmacológico , Adenosina Desaminasa/sangre , Adenosina Desaminasa/deficiencia , Diálisis , Portadores de Fármacos , Metabolismo Energético , Humanos , Inmunodeficiencia Combinada Grave/enzimologíaRESUMEN
Calcitonin inhibits bone resorption through a direct action on the osteoclast. We report a quantitative analysis of bone resorption by disaggregated rat osteoclasts. We then used our findings to develop a formal bioassay for calcitonin. Osteoclasts were mechanically disaggregated from neonatal rat long bones and dispersed at low densities on slices of devitalized bovine cortical bone. The resulting areas of bone excavation were quantified to micrometric precision by scanning electron microscopy together with computer-assisted image analysis. These findings were correlated with the volumes of bone resorption in the same slices measured by confocal scanning microscopy for the first time. The total planar areas of bone resorption per slice correlated linearly (r = 0.78) with the confocal microscopic measurements of total volume resorbed, provided that volume was expressed to its two-thirds power. The latter transformation resulted in representations of the determined areas ([length]2) and volumes ([length]3) which were dimensionally consistent. These findings thus demonstrate that osteoclastic bone excavations show a consistent relationship between area and volume and that assessments of the area of excavations accordingly provide an empirical representation of the volume of bone resorbed. Furthermore, in view of the skewed nature of the distributions of area measurements, we assessed the effect of transforming the response variable to derive a metameter, (planar area of resorption)1/2. Such transformed data points, which expressed the data in the dimensions of [length], were more normally distributed than the raw data points and had more stable variances over a wider concentration range. We accordingly determined relative potencies using parallel line analyses on the transformed data. The latter offered a consistent correlation to the volume measurements when these were also converted to dimensions of [length] (r = 0.805). It was confirmed that the inhibition of bone resorption by calcitonins from various species, namely, pig, salmon and eel, was quantitatively dependent upon concentration of the respective peptides. The resulting assay was also found to be sufficiently sensitive to measure picomolar peptide concentrations with a precision, lambda (standard deviation/slope), ranging between 0.3 and 0.8. Finally, we identified factors affecting assay precision and sensitivity.
Asunto(s)
Resorción Ósea , Calcitonina/metabolismo , Osteoclastos/metabolismo , Osteoclastos/fisiología , Animales , Bioensayo , Supervivencia Celular , Microscopía Electrónica de Rastreo , Osteoclastos/ultraestructura , Ratas , Ratas Wistar , Sensibilidad y EspecificidadRESUMEN
We examined the effects of epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) on the uptake of AIB by and its transfer across near-term human placental syncytiotrophoblast in two-sided culture. Pre-incubation of the trophoblast cell layer with either EGF (50ng/ml) or IGF-I (100ng/ml) on the apical (microvillous, in vivo maternal-facing) side reduced rates of unidirectional microvillous-to-basal transtrophoblast AIB transfer, increasing AIB retention within the cells. EGF on the basal (fetal-facing) side of the cell layer enhanced AIB uptake from the microvillous side but also increased overall mediated permeability in both directions. IGF-I at the basal surface, however, increased AIB uptake across the microvillous membrane, and induced a backflux from the cells into the basal medium dependent upon basal AIB concentration, suggesting that in vivo IGF-I on the fetal side enhances maternal-to-fetal placental transfer. The ideas are consistent with current concepts of maternal-placental and fetal-placental interactions regulating pregnancy and fetal development.
Asunto(s)
Ácidos Aminoisobutíricos/metabolismo , Factor de Crecimiento Epidérmico/farmacología , Factor I del Crecimiento Similar a la Insulina/farmacología , Trofoblastos/metabolismo , Transporte Biológico/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Factor de Crecimiento Epidérmico/fisiología , Femenino , Humanos , Factor I del Crecimiento Similar a la Insulina/fisiología , Cinética , Microvellosidades/efectos de los fármacos , Microvellosidades/metabolismo , Embarazo , Trofoblastos/efectos de los fármacosRESUMEN
Bone resorption appears to be dependent on a range of processes. It requires an adequate number of osteoclasts to access bone mineral. These osteoclasts must be activated by a mechanism which is dependent upon prior osteoblastic stimulation. A range of factors then contribute to the formation of a functionally effective resorptive hemivacuole. These entail osteoclast adhesion to the bone surface leading to the formation of a sealing zone. Only then can subsequent processes such as H+ ion transport, enzyme secretion and matrix digestion become effective. Thus, any one process is potentially limiting to resorption and is a potential target for regulation. Long-range regulation takes place through the action of hormones, of which the mode of action of calcitonin has been the subject of recent investigations in isolated osteoclasts. Such studies have shown a possible involvement of distinguishable receptor subtypes, the occupancy of which may activate at least two types of triggering mechanism. It is likely that an eventual influence on motility properties through G protein mediation accounts for the actions of this hormone and of related peptides such as amylin and CGRP at the cellular level. Similar pathways may contribute to shorter range modulation of osteoclast activity by increases in ambient Ca2+. Finally, there is recent evidence for a contribution of endothelial cell-derived product to osteoclast regulation.
Asunto(s)
Osteoclastos/fisiología , Animales , Resorción Ósea/fisiopatología , Calcitonina/fisiología , Calcio/metabolismo , Humanos , Minerales/metabolismo , Osteoblastos/fisiologíaRESUMEN
The single copy endogenous retrovirus locus ERV-3 is known to be primarily expressed in the placenta. The absence of expression of this gene in choriocarcinoma cell lines has led to speculation that this may be a defect associated with this abnormality. We show here that ERV-3 is not normally expressed in the cytotrophoblast from which these tumour cells are derived but is expressed in normal syncytiotrophoblast. The conservation of the ERV-3 open reading frame for env in ape and old world monkey species and its tight regulation and site of expression suggest a functional role for this gene in this tissue.
Asunto(s)
Retroviridae/crecimiento & desarrollo , Trofoblastos/microbiología , Regulación hacia Arriba , Secuencia de Bases , Diferenciación Celular , Células Cultivadas , Coriocarcinoma/microbiología , Femenino , Humanos , Datos de Secuencia Molecular , Embarazo , Trofoblastos/citología , Células Tumorales CultivadasRESUMEN
Cytosolic [Ca2+] was measured in single osteoclasts using fura-2 in experiments investigating the effects of Ca2+ "receptor" activation using thapsigargin as a means of depleting intracellular Ca2+ stores. Application of 4 microM thapsigargin to osteoclasts in Ca(2+)-free solutions resulted in an elevation of cytosolic [Ca2+]. Under similar conditions, activation of the osteoclast Ca2+ receptor by the substitute divalent cation agonist, Ni2+, resulted in a transient elevation of cytosolic [Ca2+]. In both instances, restoration of extracellular [Ca2+] to 1.25 mM resulted in an "overshoot" of cytosolic [Ca2+]. Prior depletion of intracellular Ca2+ stores by thapsigargin markedly reduced the magnitude of the cytosolic [Ca2+] response to a subsequent application of 5 mM Ni2+. The application of 2 microM thapsigargin to intercept the falling phase of the Ni(2+)-induced cytosolic Ca2+ signal resulted in a sustained elevation of cytosolic [Ca2+], which was terminated by a second application of the same Ni2+. Furthermore, the sustained elevation of cytosolic [Ca2+] induced by thapsigargin application alone was abolished by late application of Ni2+. We conclude that activation of the surface membrane Ca2+ receptor on the osteoclast results in the cytosolic release of Ca2+ from intracellular storage organelles; the refilling of such stores depends upon a thapsigargin-sensitive Ca(2+)-ATPase; store depletion induces capacitative Ca2+ influx; and the Ca2+ influx pathway is sensitive to blockade by Ni2+.
Asunto(s)
ATPasas Transportadoras de Calcio/antagonistas & inhibidores , Calcio/metabolismo , Osteoclastos/efectos de los fármacos , Terpenos/farmacología , Animales , ATPasas Transportadoras de Calcio/metabolismo , Citosol/metabolismo , Fura-2/química , Modelos Biológicos , Níquel/farmacología , Osteoclastos/metabolismo , Ratas , Ratas Wistar , TapsigarginaRESUMEN
Ni2+ was used as an extracellular activator of the Ca2+ 'receptor' in order to study the regulation of osteoclast function in vitro. Application of different micromolar concentrations of Ni2+ to osteoclasts bathed in 1.25 mM [Ca2+] and 0.8 mM [Mg2+] caused a concentration-dependent elevation of cytosolic [Ca2+] measured in single cells using fura-2 fluorescence. Cytosolic [Ca2+] responses to 5 mM [Ni2+] showed a rapidly developing and use-dependent inactivation, unlike those induced by the application of 10 mM [Ca2+]. Pre-treatment with 5 mM [Ni2+] reduced the magnitude of responses to a subsequent extracellular application of 10 mM [Ca2+] and vice versa. Ni2+ treatment elicited a number of functional effects. It produced an inhibition of osteoclastic bone resorption which was sustained over hours. This was associated with a pronounced cell retraction or R effect over the 40 min period following Ni2+ exposure as observed by time-lapse video image analysis. Both these effects varied with concentration. In contrast, granule movement, cell migration, and quantitative indicators of margin ruffling were all unchanged. These findings are consistent with the initiation of a causally related set of specific functional and morphometric events following activation of a specific membrane receptor sensitive to divalent cations.
Asunto(s)
Proteínas de Unión al Calcio/metabolismo , Níquel/metabolismo , Osteoclastos/fisiología , Animales , Animales Recién Nacidos , Resorción Ósea/metabolismo , Calcio/análisis , Calcio/metabolismo , Calcio/farmacología , Proteínas de Unión al Calcio/análisis , Movimiento Celular/efectos de los fármacos , Movimiento Celular/fisiología , Células Cultivadas , Citosol/química , Citosol/metabolismo , Níquel/farmacología , Osteoclastos/química , Osteoclastos/citología , Ratas , Ratas Wistar , Factores de Tiempo , Grabación en VideoRESUMEN
We report the effects of tetracycline analogues on cytosolic Ca2+ transients resulting from application of ionic nickel (Ni2+), a potent surrogate agonist of the osteoclast Ca2+ "receptor". Preincubation with minocycline (1 mg/l) or a chemically modified tetracycline, 4-dedimethyl-aminotetracycline (CMT-1) (1 or 10 mg/l), resulted in a significant attenuation of the magnitude of the cytosolic [Ca2+] response to an application of 5 mM-[Ni2+]. Preincubation with doxycycline (1 or 10 mg/l) failed to produce similar results. In addition, application of minocycline alone (0.1-100 mg/l) resulted in a 3.5-fold elevation of cytosolic [Ca2+]. The results suggest a novel action of tetracyclines on the osteoclast Ca2+ "receptor".
Asunto(s)
Calcio/análisis , Citosol/química , Osteoclastos/química , Receptores Citoplasmáticos y Nucleares/análisis , Receptores Citoplasmáticos y Nucleares/fisiología , Tetraciclina/farmacología , Animales , Calcio/metabolismo , Calcio/fisiología , Citosol/fisiología , Doxiciclina/farmacología , Minociclina/farmacología , Níquel/farmacología , Osteoclastos/fisiología , Osteoclastos/ultraestructura , Ratas , Receptores Citoplasmáticos y Nucleares/metabolismoRESUMEN
Past knowledge and the recent developments on the formation, activation and mode of action of osteoclasts, with particular reference to the regulation of each individual step, have been reviewed. The following conclusions of consensus have emerged. 1. The resorption of bone is the result of successive steps that can be regulated individually. 2. Osteoclast progenitors are formed in bone marrow. This is followed by their vascular dissemination and the generation of resting preosteoclasts and osteoclasts in bone. 3. The exact pathways of differentiation of the osteoclast progenators to mature osteoclasts are debatable, but there is clear evidence that stromal cells support osteoclast generation. 4. Osteoclasts are activated following contact with mineralized bone. This appears to be controlled by osteoblasts that expose mineral to osteoclasts and/or release a factor that activates these cells. 5. Activated osteoclasts dissolve the bone mineral and digest the organic matter of bone by the action of agents secreted in the segregated microcompartments underlying their ruffled borders. The mineral is solubilized by protons generated from CO2 by carbonic anhydrase and secreted by an ATP-driven vacuolar H(+)-K(+)-ATPase located at the ruffled border. The organic matrix of the bone is removed by acid proteinases, particularly cysteine-proteinases that are secreted together with other lysosomal enzymes in the acid environment of the resorption zone. 6. Osteoclastic bone resorption is directly regulated by a polypeptide hormone, calcitonin (CT), and locally, by ionized calcium (Ca2+) generated as a result of osteoclastic bone resorption. 7. There is new evidence that osteoclast activity may also be influenced by the endothelial cells via generation of products including PG, NO and endothelin.
Asunto(s)
Resorción Ósea/patología , Osteoclastos/citología , Animales , Resorción Ósea/fisiopatología , Calcitonina/fisiología , Calcio/fisiología , Adhesión Celular , Comunicación Celular , Diferenciación Celular , Humanos , Osteoblastos/fisiología , Osteoclastos/fisiología , Células Madre/citología , Células Madre/fisiologíaRESUMEN
An increasing number of cell types appear to detect changes in the extracellular Ca2+ concentration and and accordingly modify their function. We review recent evidence for the existence and function of such a mechanism in the osteoclast. Elevated external [Ca2+] in the mM range reduces bone resorption and results in motile changes in the cells. These changes may partly result from elevations of cytosolic [Ca2+] triggered through activation of a surface Ca2+ receptor. Closer analyses of the increases in cytosolic [Ca2+] associated with receptor activation are hindered by the action of this ion both as extracellular agonist and intracellular second messenger. Variations in the peak cytosolic [Ca2+] response to external Ca2+ with changes in cell membrane potential by K+ and valinomycin establish a contribution from extracellular Ca2+. Use of CIO4-, Ni2+ and Cd2+ as surrogate activators in low extracellular [Ca2+] indicate a contribution from Ca2+ release from intracellular stores as well. Such agonists also modify Ca2+ redistribution in other systems, such as skeletal muscle. Thus, we may gain insights into osteoclast extracellular Ca2+ detection and transduction from known features of more well-characterised cell systems.